ABOUT 4-DAMP

Dosages really should be individualized according to the advisable goal of therapy plus the patient’s response.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria are already described with other HMG-CoA reductase inhibitors. This hasn't been described with cerivastatin sodium so far. Cerivastatin therapy really should be discontinue